H.Con.Res. 75 · 109th Congress

Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.

Stage
In committee
Introduced
2005-02-17
Latest action
2005-03-14 · Referred to the Subcommittee on Health.

Subjects

Health
Crime prevention
Foreign trade and international finance
Research and development
Commerce
Canada
Science, Technology, Communications
Access to health care
Economics and Public Finance
Crime and Law Enforcement
Social Welfare
Smuggling
Consumer education
Imports
Health education
Drug approvals
Drugs
Pharmaceutical research
Prescription pricing
Consumer protection
Deregulation
Price discrimination
Drug industry
Health care industry
Price regulation